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a b s t r a c t
Mammalian embryos develop in a low oxygen environment. The transcription factor hypoxia inducible factor
1a (HIF1α) is a key element in the cellular response to hypoxia. Complete deletion of Hif1α from the mouse
conceptus causes extensive placental, vascular and heart defects, resulting in embryonic lethality. However
the precise role of Hif1α in each of these organ systems remains unknown. To further investigate, we
conditionally-deleted Hif1α from mesoderm, vasculature and heart individually. Surprisingly, deletion from
these tissues did not recapitulate the same severe heart phenotype or embryonic lethality. Placental
insufﬁciency, such as occurs in the complete Hif1α null, results in elevated cellular hypoxia in mouse
embryos. We hypothesized that subjecting the Hif1α conditional null embryos to increased hypoxic stress
might exacerbate the effects of tissue-speciﬁc Hif1α deletion. We tested this hypothesis using a model system
mimicking placental insufﬁciency. We found that the majority of embryos lacking Hif1α in the heart died
when exposed to non-physiological hypoxia. This was a heart-speciﬁc phenomenon, as HIF1α protein
accumulated predominantly in the myocardium of hypoxia-stressed embryos. Our study demonstrates the
vulnerability of the heart to lowered oxygen levels, and that under such conditions of non-physiological
hypoxia the embryo absolutely requires Hif1α to continue normal development. Importantly, these ﬁndings
extend our understanding of the roles of Hif1α in cardiovascular development.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The hypoxia inducible factor 1 (HIF1) is a key element in the cell's
response to hypoxia. It is a heterodimeric transcription factor con-
sisting of HIF1α and aryl hydrocarbon receptor nuclear trans-
locator (ARNT). HIF1 affects processes as broad as angiogenesis,
inﬂammation, epithelial to mesenchymal transition, metabolism,
differentiation, proliferation and apoptosis (Eisinger-Mathason et al.,
2013; Eltzschig and Carmeliet, 2011; Lendahl et al., 2009; Prabhakar
and Semenza, 2012; Schlaeger et al., 1997). In cell culture, HIF1α has a
half-life of o5 min at a PO2 of 140 mmHg (20% oxygen) (Wang et al.,
1995). HIF1α has enhanced stability and activity when cellular PO2
falls below 42 mmHg, with a half maximal response at 10.5 mmHg
and a maximal response at 3.5 mmHg (Jiang et al., 1996; Lando et al.,
2002a, 2002b).
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Compared with adults, mammalian embryos develop in a low
oxygen environment (physiological hypoxia). At sea level the
partial pressure of oxygen (PO2) is 155 mmHg with oxygen
comprising 21% of air, but adult tissue PO2 levels are reported to
range widely, with direct measurement techniques detecting the
highest levels in lung tissue and the lowest levels in the superﬁcial
skin (reviewed in Carreau et al., 2011; Land, 2004). During gestation,
human maternal arterial and venous PO2 are around half that of air,
and low oxygen tensions are a feature of the gestational environment
from conception (55 mmHg) through embryo implantation and
early placentation (0–13 mmHg). Even in late gestation, where
placental gas exchange facilitates oxygen delivery to the fetus, the
PO2 values for the umbilical artery and vein are 30% that of the
respective maternal values. Cellular PO2 can also be measured
indirectly using nitroimidazole derivatives such as pimonidazole
hydrochloride (hypoxyprobe™, Raleigh et al., 1999). Such techniques
have revealed that tissues in different regions of the mouse embryo
have a PO2 of r10 mmHg at a variety of stages of development
(Dunwoodie, 2009; Lee et al., 2001; Ream et al., 2008).
A number of studies report the effects of loss of Hif1α in mice, but
evidence suggests that the story may not be so simple. Firstly, it is
accepted that Hif1α is essential for normal mouse embryo develop-
ment and survival (Compernolle et al., 2003; Cowden Dahl et al.,
2005; Iyer et al., 1998; Kotch et al., 1999; Ryan et al., 1998). However,
complete deletion of Hif1α from the mouse conceptus causes
extensive placental and cardiovascular defects, resulting in elevated
cellular hypoxia, and lethality by embryonic day (E) 10.5. Here, the
lack of placental formation creates a hypoxic environment for
embryogenesis. Therefore, we do not know the speciﬁc roles of
Hif1α in cardiovascular development during normal embryogenesis;
that is embryogenesis under conditions of physiological hypoxia with
a functioning placenta. It is possible that Hif1α is required equally for
the development of the placenta, vasculature and heart, and that
these three interdependent systems develop in parallel. Alternatively,
Hif1α might have a primary function in only one of these systems,
which then impacts on the development of the others. Secondly,
conditional deletion of Hif1α indicates roles in bone development,
and in adult mice roles in angiogenesis and heart function (Huang
et al., 2004; Kisanuki et al., 2001; Tang et al., 2004). Moreover, during
the course of our study, additional roles for Hif1α have been
indicated in development of the limb, heart and hematopoietic
system (Amarilio et al., 2007; Imanirad et al., 2013; Krishnan
et al., 2008; Provot et al., 2007). However, incomplete deletion of
Hif1α and other factors (see Discussion) also suggests that we still do
not have a clear understanding of its role during cardiovascular
development.
Here we address the speciﬁc role(s) of Hif1α in development of the
heart and vasculature of the mouse by deleting Hif1α from these
systems individually, using a ﬂoxed Hif1α allele and Cre recombinase
technology. Surprisingly, deletion of Hif1α from these tissues individu-
ally did not recapitulate the same severe cardiovascular phenotype or
embryonic lethality as seen in complete Hif1α null conceptuses.
This indicates that Hif1a is not required for development of the heart
or vasculature under normal conditions. We further demonstrate
that there is a strong Gene–environment interaction occurring in this
system, whereby elevated cellular hypoxia, such as occurs in the
complete Hif1α null due to placental insufﬁciency, exacerbated
the effects of Hif1α deletion. In these experiments, the majority of
embryos lacking Hif1α in the heart died when exposed to non-
physiological hypoxia. This appeared to be a heart-speciﬁc phenom-
enon, as nuclear HIF1α protein accumulated predominantly in the
myocardium of hypoxia-stressed embryos. We conclude that of all the
tissues in the developing mouse embryo, the heart is the most
susceptible to gestational hypoxia, and that Hif1α expression in the
developing heart is crucial for embryo survival under such hypoxic
conditions.
Methods
Mouse lines and genotyping
This research was performed following the guidelines, and with
the approval, of the Garvan Institute of Medical Research/St.
Vincent's Animal Experimentation Ethics Committee, research
approvals 09/33 and 12/33. Mouse lines carrying targeted alleles
and randomly inserted transgenes used in these studies are as
follows:
Tek-Cre [Tg(Tek-cre)12Flv] (Koni et al., 2001);
MesP1Cre [MesP1tm2(cre)Ysa] (Saga et al., 1999);
Hif1αﬂox [Hif1αtm3Rsjo] (Ryan et al., 2000); and
Hif1αΔ [Hif1αtm3.1Rsjo]
These mouse lines were all backcrossed for a minimum of ten
generations into the C57BL/6J genetic background, and were
maintained on this background.
Nkx2-5IRESCre [Nkx2-5tm2(cre)Rph] (Stanley et al., 2002). For this
line, mice were maintained on a 129/SvJ;SJL;C57BL/6J hybrid
genetic background.
Mice and embryos were genotyped by PCR using the following
primers:
Cre 50-CATTTGGGCCAGCTAAACAT-30 and
5′-ATTCTCCCACCGTCAGTACG-30
Hif1αΔ 50-TGGGGATGAAAACATCTGCT-30 and 50-GCAGTTAA-
GAGCACTAGTTG-30
Hif1αﬂox 50–GCTAAGGAAGTAAGCACCTGGA-30 and 50–TCGAC-
GTTCAGAACTCATCCT-30
Mice heterozygous for the Hif1αΔ allele (Hif1αΔ/þ) were
crossed with mice carrying various Cre alleles. For the transgenic
Cre allele (Tek-Cre), Hif1αΔ/+ Creþ males were mated with
Hif1αﬂox/ﬂox females, generating three control genotypes: Hif1αþ /ﬂox
Cre

; Hif1α/+/ﬂox Creþ; Hif1αΔ/ﬂox Cre; and the conditionally
deleted genotype Hif1αΔ/ﬂox Creþ . For knock-in Cre alleles
(MesP1Cre and Nkx2-5IRESCre), male double heterozygotes (Hif1αΔ/+
Creþ /) were mated with Hif1αﬂox/ﬂox females, generating three
control genotypes: Hif1α/+/ﬂox Cre /; Hif1α/+/ﬂox Creþ /; Hif1αΔ/ﬂox
Cre /; and the conditionally deleted genotype Hif1αΔ/ﬂox Creþ / .
Embryos and placentas were collected at various stages of devel-
opment, and were weighed and genotyped.
Heart morphology analysis
Heart morphology of all conditionally deleted embryos
(Hif1αΔ/ﬂox Creþ /) was assessed using wax sectioning. To increase
throughput, about half of control embryos were initially screened
by magnetic resonance imaging (MRI). All defects visualized by
MRI were subsequently wax sectioned for conﬁrmation. The
remaining control embryos were wax sectioned without prior
MRI analysis. For wax sectioning, whole E17.5 embryos were ﬁxed
in Bouin's solution overnight, the heart-lung complex manually
dissected, and 7 μm frontal sections (with respect to the heart)
were cut and stained with haematoxylin and eosin by standard
methods. For MRI, whole E17.5 embryos were ﬁxed in either
Bouin's solution or 4% paraformaldehyde in PBS, then two
embryos set in tubes in 4% agarose gel containing a Gadolinium-
based contrast agent (2 mM Gadopentetate dimeglumine, Bayer).
The embryos were stored at 4 1C prior to MRI and were imaged
within 7 days of preparation. High resolution ex vivo MRI images
were acquired using a vertical bore 9.4T magnet (Oxford
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Instruments) interfaced to a Biospec Bruker spectrometer running
ParaVision 5.1 (Bruker). A shielded gradient system with a max-
imum gradient strength of 548 mTesla/m and a rise time of 160 μs
was used (Magnex Scientiﬁc). The resonator for all experiments
was a 15 mm birdcage coil (m2m Imaging Corp.). 3D gradient
echo images (3DGE) T1-weighted images were acquired using a
protocol similar to that previously described at an isotropic voxel
resolution of 35 μm (Schneider et al., 2003). The following
parameters were used: NA¼2; TE¼11 ms; TR¼40 ms; 90 degree
excitation pulse; matrix¼768512512; FOV: 18 mm
18 mm27 mm. Frequency encoding was performed along the
long axis of the magnet (bandwidth¼105 Hz/pixel). Total acquisi-
tion time per embryo was approximately 6 h. Data were recon-
structed off-line using custom code written in MATLAB (The
MathWorks Co.). Data were initially zero-ﬁlled to a nominal
isotropic pixel resolution of 17.5 μm, then reformatted for ease of
interpretation as axial images with a cropped ﬁeld of view
containing a single embryo only. Image analysis was performed
on a Macintosh personal computer using Osirix (http://www.
osirix-viewer.com, Rosset et al., 2004). Data were initially viewed
in the axial plane, then were reformatted using oblique cuts in the
3D module to resolve any ambiguities. Heart morphology for all
samples was initially assessed by the same operator, with classi-
ﬁcation of heart defects conﬁrmed by an independent observer.
Samples with ventricular septal defects (VSD) were further classi-
ﬁed as double-outlet right ventricle (DORV) if on a frontal section
the aorta was positioned wholly to the right of the ventricular
septum (VS), and as overriding aorta if the aorta was positioned
equally over both ventricles.
Quantitative PCR
Genomic DNA was isolated from E9.5 heart tissue, and qPCR
performed using TaqMans probes for Hif1α (Custom Plus Assay
designed to detect both Hif1α wild type and Hif1αﬂox alleles) and
β-actin (Mm02619580_g1). Assays were performed in triplicate
and a standard curve was generated using embryonic hearts from
Cre-negative embryos.
For transcript analysis, E9.5 embryo hearts were isolated,
mRNA extracted (PureLink™ kit with DNaseI treatment, Invitro-
gen), and reverse transcribed (SuperScripts VILO™ cDNA synth-
esis kit, Invitrogen). Transcript levels were determined using
the following TaqMans gene expression assays (Applied Biosys-
tems): Hif1α (Mm01283757_m1), β-actin (Mm01205647_g1), Tbx5
(Mm00803518_m1) and Nkx2-5 (Mm00657783_m1). Assays were
performed in triplicate with FAM-labeled test probe and VIC-
labeled β-actin probe as an internal control. Reactions were done
using Lightcyclers 480 Probes Master (Roche Applied Science),
and were run on a Roche Lightcyclers 480 (Roche Applied
Science).
Maternal low oxygen exposure
Dams were exposed to varying levels of reduced oxygen at
normal atmospheric pressure for 8 h at E9.5 as previously
described (Sparrow et al., 2012).
Quantiﬁcation of embryonic levels of hypoxia
Wild-type C57BL/6J dams were injected peritoneally with
hypoxyprobe™ (pimonidazole hydrochloride, Hypoxyprobe Inc.)
at 60 mg/kg prior to 3 h of maternal low oxygen exposure.
Embryos (E9.5) and embryonic tissues (E12.5) were collected and
frozen prior to whole cell protein extraction and western blotting
using FITC-conjugated IgG1 monoclonal antibody (Hypoxyprobe
Inc.) and Rabbit anti-FITC HRP antibody (Hypoxyprobe Inc.) as
previously described (Sparrow et al., 2009). The β-tubulin loading
control was quantiﬁed using a goat anti-β-tubulin antibody
(T5201, Sigma-Aldrich) and a donkey anti-goat AlexaFluor™ 680
secondary antibody (Jackson ImmunoResearch).
Immunostaining and mitotic index determination
HIF1α expression was analyzed by immunoﬂuorescence in
either wholemount or on wax sections using an anti-HIF1α anti-
body (NB100-449, Novus Biologicals) and a donkey anti-rabbit Cy3
secondary antibody (Jackson ImmunoResearch) as previously
described (Geffers et al., 2007). Nuclei were counterstained with
TO-PRO3 (Life Technologies). Images were captured on a LSM 710
confocal microscope (Carl Zeiss Microscopy). Myocardial prolifera-
tion was assessed by wholemount immunoﬂuorescence using an
anti-phospho-Histone H3 (Ser10) antibody (06-570, Merck Milli-
pore) and a donkey anti-rabbit Cy3 antibody (Jackson ImmunoR-
esearch). Nuclei were counterstained with DAPI. A z series of
optical sections 1.5 mm apart encompassing the entire heart were
captured. Every 20th optical section, a total of 4–7 sections per
heart, was analyzed using ImageJ software (NIH) and the mean
mitotic index calculated. This was expressed as the percentage of
phospho-Histone H3 positive area per total myocardial area.
Statistical analyses
Statistical analyses were performed using Microsoft Excel and
Prism 6 (GraphPad Software Inc). Statistical signiﬁcance of embryo
survival across genotype groups was tested by Chi-squared test. For
statistical analysis of weights, embryo and placenta weights from
Hif1α deleted samples (Hif1αΔ/ﬂox Creþ /) were normalized against
the averaged weights of control littermates, and the normalized
weights for each genotype group were analyzed using Student's t-
test. Signiﬁcance in the heart defect prevalence between genotype
groups was tested using one-tailed Fisher's exact test. Signiﬁcance
of qPCR, western blots and mitotic index were tested using
Student's t-test. Where the data were bounded by zero (RT qPCR),
the data were transformed using natural logarithms to correct for
right-skew prior to analysis by Student's t-test.
Results
Deletion of Hif1α from mesoderm leads to heart defects and embryo
lethality
Complete deletion of Hif1α from the mouse conceptus results
in extensive placental, vascular and heart defects, resulting in
embryonic lethality by embryonic day (E) 10.5 (Compernolle et al.,
2003; Cowden Dahl et al., 2005; Iyer et al., 1998; Kotch et al., 1999;
Ryan et al., 1998). Therefore it is difﬁcult to identify where Hif1α
speciﬁcally functions during development. We used conditional
deletion to directly address this issue. We ﬁrst conditionally
deleted Hif1α from mesoderm using the MesP1Cre allele. This
allele is expressed in embryonic and extra-embryonic mesoderm
from E6.5 (Saga et al., 1999) and therefore deletes DNA in a broad
range of mesoderm in both the embryo, including the heart
and vasculature, as well as in the placenta. We crossed
Hif1αΔ/þ MesP1Creþ / males with Hif1αﬂox/ﬂox females and col-
lected embryos and placentas at E17.5 (when heart development is
essentially complete). As a comparison, we intercrossed Hif1αΔ/+
mice, and collected embryos and placentas at E17.5. As expected
from previous studies, complete deletion of Hif1α results in 100%
embryo lethality by E17.5 (Fig. 1A), by contrast, deletion of Hif1α
from mesoderm led to 55% embryo lethality (Fig. 1A; Table S1).
Surviving conditionally-deleted embryos were signiﬁcantly lighter
V.C. O'Reilly et al. / Developmental Biology 391 (2014) 99–110 101
than their control littermates (Fig. S1). Analysis of heart morphol-
ogy at E17.5 identiﬁed a signiﬁcantly increased prevalence of heart
defects in conditionally-deleted embryos (6/17 compared with
1/28 of controls analyzed; Fig. 1B; Table S1; Fig. S1A, defective
embryos indicated in red). The heart defects in the conditionally
deleted embryos included ventricular septal defect (VSD), over-
riding aorta (OA) and ectopia cordis (EC) (Fig. 2; Table S1). In
summary, Hif1α is required in mesoderm for survival and for
normal development of the heart. Its absence from mesoderm leads
to 55% embryo lethality, and 35% of surviving conditionally-
deleted embryos develop heart defects (Fig. 1A and B).
Deletion of Hif1α from vascular endothelial cells impacts on
development of the placenta and embryo
Deletion of Hif1α from mesoderm resulted in signiﬁcant heart
defects and embryonic lethality. The mesoderm gives rise to both
the vasculature (embryonic and placental) and the heart, and we
considered that expression of Hif1α in either or both of these
tissues might be important for causing heart defects and/or
lethality. We ﬁrst sought to determine if the observed defects
were caused by loss of Hif1α in the vasculature alone. We there-
fore conditionally deleted Hif1α from vascular endothelial cells
(VECs) and hematopoietic cells using the Tek-Cre transgene
(Constien et al., 2001; Tang et al., 2004). This transgene drives
expression of Cre recombinase in all VECs from E7.5 (Koni et al.,
2001) in both embryonic and extra-embryonic vessels, including
those of the yolk sac and placenta. In the heart, Tek-Cre is
expressed in the endocardium, the myocardial vasculature, the
mesenchymal cells of the proximal outﬂow tract, the atrioventri-
cular canal and in the developing leaﬂets of the pulmonary and
aortic valves (Kisanuki et al., 2001; Schlaeger et al., 1997). We
crossed Hif1αΔ/þ Tek-Creþ males with Hif1αﬂox/ﬂox females and
collected embryos and placentas at E17.5. Deletion of Hif1α from
VECs had no affect on embryo survival (Table S2), although both
embryos and placentas were signiﬁcantly lighter than controls
(Fig. S2). Vascular defects such as hemorrhage or edema were not
apparent in embryos. Analysis of heart morphology at E17.5
identiﬁed heart defects in 15% of conditionally-deleted embryos
(2/13 compared with 0/10 of controls analyzed; Table S2; Fig. S2,
defective embryos indicated in red). However the prevalence of
heart defects in these embryos was not signiﬁcantly increased
over controls. The heart defects were VSD with OA or double-
outlet right ventricle (DORV) (Table S2; Fig. 2). Notably, the
embryos with heart defects were signiﬁcantly lighter than the
other embryos of the same genotype (Fig. S2A). In summary, Hif1α
is required in the vasculature of the yolk sac, placenta and/or
embryo for normal embryo and placental growth, and its loss in
VECs may contribute to a low prevalence of heart defects.
Deletion of Hif1α from cardiac precursor cells results in reduced
placental and embryo weight, and may impact heart development
Since the majority of heart defects and embryonic lethality
caused by the loss of Hif1α in mesoderm did not appear to be due
to a requirement for Hif1α in VECs, we next sought to condition-
ally delete Hif1α from cardiac precursors and derivatives using the
Nkx2-5IRESCre allele. This allele is expressed in the ﬁrst and second
heart ﬁelds from E7.75, with recombinase activity evident
throughout the myocardium as development proceeds (Stanley
et al., 2002). Later in development, this allele is also expressed in a
number of extra-cardiac regions, including derivatives of the
pharyngeal ﬂoor and foregut endoderm including the lung epithe-
lium, and parts of the liver, thyroid, spleen, pancreas and stomach
(Stanley et al., 2002). We crossed Hif1αΔ/þ Nkx2-5IRESCreþ / males
with Hif1αﬂox/ﬂox females and collected embryos and placentas at
E17.5. Deletion of Hif1α from the heart did not affect embryo
survival (Fig. 1A; Table S3), but these embryos and their placentas
were signiﬁcantly lighter than controls (Fig. S3). Analysis of heart
morphology revealed that 14% of these embryos had heart defects
(3/21 embryos with VSD, OA, DORV, straddling and overriding
tricuspid valve (SOTV); Fig. 1B; Fig. S3, defective embryos indi-
cated in red). However, 2/55 controls also had heart defects (VSD
with OA), therefore this was not a signiﬁcantly increased pre-
valence. In summary, Hif1α expression in the heart is required for
normal embryo and placenta growth, and its absence from the
Fig. 1. Embryonic survival and prevalence of heart defects following embryonic Hif1α deletion. (A) Histograms showing the estimated percentage of embryos that survived
until E17.5 following total embryonic Hif1α deletion (Hif1αΔ), or conditional deletion in mesoderm (MesP1Cre) or cardiac progenitor cells (Nkx2-5Cre). (B) Histograms showing
the percentage of heart defects present in surviving E17.5 embryos that were analyzed for heart morphology following embryonic Hif1α deletion in mesoderm (MesP1Cre) or
cardiac progenitor cells (Nkx2-5Cre). wt/het represents pooled homozygous wild type and heterozygous Hif1αΔ embryos, null represents homozygous Hif1αΔ embryos,
(C) represents pooled embryos from all three control genotypes from Cre crosses, and Hf/HΔ Creþ represents conditionally deleted embryos.
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heart during development may contribute to a low prevalence of
heart defects.
Hif1α is deleted from the heart using MesP1Cre or Nkx2-5IRESCre
Although deletion of Hif1α from all embryonic and extra-
embryonic tissues causes completely penetrant heart defects and
embryo lethality (Compernolle et al., 2003; Cowden Dahl et al.,
2005; Iyer et al., 1998; Kotch et al., 1999; Ryan et al., 1998), in our
study where Hif1α is essentially deleted from the mesoderm
(MesP1Cre) or the heart (Nkx2-5IRESCre), we observed a much
reduced prevalence of lethality and heart defects. This disparity
might be due to incomplete deletion of the ﬂoxed Hif1α allele in
our system. We therefore investigated the extent of Hif1α deletion
from the heart for both Cre alleles. First we used qPCR to
determine the copy number of the wild-type Hif1α allele in
genomic DNA from E9.5 mouse hearts of each of the four
genotypes resulting from Hif1αΔ/+ Creþ / by Hif1αﬂox/ﬂox crosses.
We used β-actin (2 copies) as an internal control. Deletion by both
MesP1Cre and Nkx2-5IRESCre resulted in approximately the expected
Hif1α copy number in each genotype (Fig. 3A and B). This suggests
that both Cre alleles efﬁciently deleted Hif1α DNA by E9.5. Despite
efﬁcient deletion at the genomic level, it is possible that Hif1α
transcripts perdure in the cell after genomic deletion. To test if this
was the case, we isolated poly Aþ RNA from E9.5 mouse hearts of
each of the four genotypes resulting from Hif1αΔ/þ Creþ / by
Hif1αﬂox/ﬂox crosses, and used qRT-PCR to determine the abun-
dance of Hif1α transcripts, relative to an internal control (β-actin).
Deletion by either MesP1Cre or Nkx2-5IRESCre resulted in an
almost total absence of Hif1α transcripts in the Hif1αΔ/ﬂox Creþ /
genotype compared with all 3 other groups (Fig. 3C and D).
In conclusion, Hif1α DNA was essentially deleted in hearts of
Hif1αΔ/ﬂox Creþ / embryos by E9.5, and virtually no transcripts of
this gene remained at this stage.
Exposure of MesP1Cre conditionally-deleted embryos to short-term
hypoxia reduces embryo survival
In our system, Cre-mediated mesoderm- or cardiac-speciﬁc
deletion of Hif1α did not generate the same severe heart pheno-
type as the complete null (Compernolle et al., 2003; Iyer et al.,
1998; Kotch et al., 1999; Ryan et al., 1998). The Hif1α complete null
embryos differ from our mesoderm- or cardiac-speciﬁc deleted
embryos because they are associated with placental insufﬁciency
(Cowden Dahl et al., 2005). We have shown that relatively mild
defects in placenta formation causes placental insufﬁciency, result-
ing in elevated cellular hypoxia in mouse embryos (Sparrow et al.,
2009). Complete deletion of Hif1α essentially prevents the pla-
centa from forming, resulting in non-physiological hypoxia in
embryos (Ryan et al., 1998). In such embryos, the expected
increase in requirement of HIF1α may lead to defects in tissues
lacking this gene. We hypothesized that subjecting the Hif1α
conditional null embryos to increased hypoxic stress might
exacerbate the prevalence or severity of heart defects. To test this
hypothesis, we used our method of exposing pregnant mice to an
atmosphere with reduced oxygen concentration at normal pres-
sure for 8 h at E9.5 (Sparrow et al., 2012). Whilst this induces
short-term embryonic hypoxia, it is unlikely to match the placen-
tal insufﬁciency that likely occurs over a number of days in Hif1α
nulls; nevertheless it is sufﬁcient to increase the severity and
penetrance of vertebral defects in genetically-susceptible embryos
(Sparrow et al., 2012). We investigated the effects of maternal low
oxygen exposure on embryos with Hif1α deleted from mesoderm
using the MesP1Cre allele. Crosses were performed as above, then
pregnant mice were exposed to an atmosphere with reduced
oxygen for 8 h at E9.5. After exposure, pregnant mice were
returned to normoxia and the embryos allowed to develop until
harvest at E17.5. Embryo and placenta weights were recorded, and
heart morphology determined as above. We commenced with
7% oxygen as this level of maternal exposure does not impact on
the survival of wild-type embryos (Sparrow et al., 2012). The
combination of exposing pregnant mice to 7% oxygen and a lack of
Hif1α in embryonic mesoderm signiﬁcantly increased embryonic
Fig. 2. Examples of heart defects identiﬁed following Hif1α deletion. Histological
sections of E17.5 mouse hearts after conditional deletion of Hif1α showing
examples of the most common types of defects identiﬁed. (A) Normal heart,
(B) ventricular septal defect (VSD) with overriding aorta (OA) from a Hif1αΔ/ﬂox
Tek-Cre embryo, and (C) straddling and overriding tricuspid valve (SOTV) from
a Hif1αΔ/ﬂox Nkx2-5IRESCre embryo. Scale bar represents 350 μm.
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lethality (91%) compared with unexposed embryos of the same
genotype (55%; Fig. 4A). This strongly suggests that there was a
signiﬁcant Gene–environment interaction in this system. In addi-
tion, surviving embryos were signiﬁcantly lighter than exposed
controls (Fig. S4A). Litters exposed to 8% oxygen showed similar
results (Fig. 4A; Fig. S4B). In both cases only about 9–13% of
embryos lacking Hif1α in mesoderm survived, and collectively 4/5
had major heart defects (Fig. 4B; Tables S4 and S5). Since virtually
all embryos that lacked Hif1α in mesoderm died following maternal
exposure to 7–8% oxygen, we were unable to determine if those
that survived had a signiﬁcantly increased prevalence of heart
defects compared to non-exposed conditionally deleted embryos.
To further investigate this point, we next exposed pregnant mice to
12% oxygen for 8 h at E9.5 and analyzed them as above. At this level
of maternal exposure embryo lethality was not increased over that
observed under normoxia (Fig. 4A). Embryos were signiﬁcantly
lighter than exposed controls (Fig. S4C). Analysis of heart morphol-
ogy revealed a slight but non-signiﬁcant increase in the prevalence
of heart defects in embryos lacking Hif1α in mesoderm comparing
maternal exposure to 12% oxygen or normoxia (9/17 compared with
6/17; Fig. 4B; Tables S1 and S6). Taken together, these data
demonstrate that maternal exposure to lowered oxygen levels
signiﬁcantly increases the prevalence of lethality in embryos lacking
Hif1α in mesoderm. Interestingly, maternal exposure at 7–8%
oxygen resulted in an almost completely penetrant embryonic
lethality (89%; Fig. 4A), similar to the fully penetrant lethality
reported for Hif1α complete null embryos. This suggests that
maternal exposure to short-term hypoxia can in part replicate the
non-physiological hypoxia generated by placental insufﬁciency
occurring in complete Hif1α null embryos.
Exposure of Nkx2-5IRESCre conditionally-deleted embryos to short-
term hypoxia reduces embryo survival
Having demonstrated an increased requirement for Hif1α in
embryonic mesoderm under hypoxic conditions, we next sought
to determine if a lack of Hif1α in the heart alone could be sufﬁcient
to impair embryo survival and/or heart development under such
conditions. We investigated the effects of maternal low oxygen
exposure on embryos with Hif1α deleted from the heart using the
Nkx2-5IRESCre allele. Crosses were performed as above, pregnant
mice were exposed to an atmosphere with reduced oxygen for 8 h
at E9.5, returned to normoxia, and the embryos allowed to develop
until E17.5 before harvest. Embryo and placenta weights were
recorded, and heart morphology determined as above. In the
MesP1Cre experiments described above, there was no observed
difference between the phenotypes of embryos whose mothers
were exposed to 7% or 8% oxygen. Therefore we used the higher
oxygen concentration for the Nkx2-5IRESCre experiments. The com-
bination of exposing pregnant mice to 8% oxygen and a lack of
Hif1α in the embryonic heart signiﬁcantly reduced embryo survi-
val (64%) compared with unexposed embryos (9%; Fig. 4C).
In addition, surviving embryos were signiﬁcantly lighter than
exposed controls (Fig. S5A). Analysis of heart morphology showed
a slight but non-signiﬁcant increase in the prevalence of heart
defects in embryos lacking Hif1α in the heart between 8% oxygen
and normoxia (2/9 compared with 3/21; Fig. 4D; Tables S3 and S7).
Similarly, maternal exposure to 9% oxygen also signiﬁcantly
reduced the survival of embryos lacking Hif1α in the heart
(77%) compared with embryos of the same genotype exposed
to normoxia (9% lethality; Fig. 4C). In addition, surviving
Fig. 3. Hif1α genomic and transcript levels in Hif1αΔ/ﬂox Mesp1Cre and Nkx2-5IRESCre mouse lines. (A, B) Genomic DNA was isolated from E9.5 embryonic hearts from the
Hif1αΔ/ﬂox Mesp1Cre (A) or Nkx2-5IRESCre (B) mouse lines. Hif1α copy number was determined using qPCR with β-actin as an internal control. (C, D) poly Aþ RNAwas extracted
from E9.5 embryonic hearts from the Hif1αΔ/ﬂox Mesp1Cre (C) or Nkx2-5IRESCre (D) mouse lines. Relative levels of Hif1α transcripts were determined by qRT-PCR using β-actin as
an internal control. Error bars indicate standard deviations. For transcript levels, statistical signiﬁcance was determined using a one-tailed Student's t-test on data
transformed using natural logarithms to correct for zero-bounded data. nnnnpo0.0001. Hf/Hþ Cre , Hf/Hþ Creþ and Hf/HΔ Cre represent the three control genotypes; and
Hf/HΔ Creþ represents conditionally deleted embryos.
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embryos were signiﬁcantly lighter than exposed controls (Fig. S5B).
Analysis of heart morphology showed a small but non-signiﬁcant
increase in the prevalence of heart defects in embryos lacking
Hif1α in the heart at 9% oxygen and normoxia (2/6 compared with
3/21; Fig. 4D; Tables S3 and S8). Given that exposing embryos
lacking Hif1α in the heart to 8-9% oxygen profoundly affected
lethality, we exposed pregnant mice carrying such embryos to 12%
oxygen for 8 h at E9.5 and analyzed them as above. In embryos
lacking Hif1α in the heart, maternal exposure to 12% oxygen did
not affect survival (Fig. 4C), nor did it affect the prevalence of heart
defects compared with normoxia (5/32 compared with 3/21;
Fig. 4D; Tables S3 and S9). Surviving embryos were signiﬁcantly
lighter than exposed controls (Fig. S5C). Taken together, these data
demonstrate that maternal exposure to lowered oxygen levels
signiﬁcantly increases the prevalence of embryonic lethality, and
may also increase the prevalence of heart defects in embryos
lacking Hif1α in the heart.
Maternal exposure at 8–9% oxygen, a level of oxygen that does
not adversely impact the survival of control embryos, resulted in
64–77% lethality of embryos lacking Hif1α in the heart. In
addition, heart defects were observed in 22–33% of surviving
conditionally deleted embryos (Fig. 4C and D). To further investi-
gate the timing of lethality, we repeated the crosses described
above. Pregnant mice were exposed to 9% oxygen for 8 h, then
returned to normoxia prior to embryo collection at E10.5. Control
mice were maintained in normoxic conditions until embryo
harvest at E10.5. At this stage, embryos of all genotypes were
present in equal numbers, but there was a signiﬁcantly increased
prevalence of abnormality in conditionally deleted embryos
exposed to 9% oxygen compared with normoxia (11/18 compared
Fig. 4. Embryonic survival and prevalence of heart defects following embryonic Hif1α deletion and maternal exposure to lowered oxygen levels. (A, C) Histograms showing
the estimated percentage of embryos that survived until E17.5 following embryonic Hif1α deletion in mesoderm (A) or cardiac progenitor cells (C) with maternal exposure to
the indicated level of oxygen for 8 h on E9.5. Normoxia (21% oxygen) represents the unexposed control. The statistical signiﬁcance of the deviation of the numbers of
surviving embryos for each of the four genotypes from the expected 1:1:1:1 Mendelian ratio was calculated using chi-squared tests. (B, D) Histograms showing the
percentage of heart defects present in surviving E17.5 embryos that were analyzed for heart morphology following embryonic Hif1α deletion in mesoderm (B) or cardiac
progenitor cells (D) with maternal exposure to the indicated oxygen level. C represents pooled embryos from all three control genotypes, and Hf/HΔ Creþ represents
conditionally deleted embryos.
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with 1/17; Tables S10 and S11). At 9% oxygen, 2/18 of these
embryos were very small and were necrotic; 9/18 were smaller
than littermates and 6 of these also had an enlarged pericardial sac
(data not shown). However, despite these defects all of the non-
necrotic embryos (9/18) had normal heart morphology, with
correct looping and normal chamber morphology (data not
shown). This suggests that embryos lacking Hif1α in the heart
are very vulnerable to in utero exposure to lowered oxygen levels,
and such exposure rapidly triggers embryonic lethality.
Short-term exposure of pregnant mice to low oxygen increases
embryonic hypoxia and stabilization of HIF1α in the heart
To investigate the molecular consequences of short-term low
oxygen exposure in embryos, we examined cellular hypoxia and
the response of HIF1α protein in embryos immediately following
such exposure. Firstly, we used hypoxyprobe™ (pimonidazole
hydrochloride) to measure cellular hypoxia in embryos. Hypoxyp-
robe™ is reductively activated, forming adducts with thiol groups
in cells experiencing r2% oxygen (Mahy et al., 2003; Raleigh et
al., 1999). These adducts can be detected using a speciﬁc antibody
(Kennedy et al., 1997). To assess the relative levels of cellular
hypoxia in exposed and unexposed embryos, we injected pregnant
mice with hypoxyprobe™ at E9.5, exposed them to 8% oxygen for
3 h (whilst control mice remained at normoxia), then harvested
the embryos and quantiﬁed the hypoxia using western blotting as
previously described (Sparrow et al., 2009). Cellular hypoxia was
dramatically increased in exposed embryos (Fig. 5A and B).
Secondly, we compared HIF1α protein levels in exposed and
control embryos in vivo using wholemount immuﬂuorescence.
Hif1α is constitutively transcribed and translated in cells, but
under normoxic conditions the HIF1α protein has an extremely
short half-life of less than 5 min (Huang et al., 1996; Yu et al.,
1998). Under hypoxic conditions HIF1α is stabilized and rapidly
accumulates in the nucleus, activating its target genes (Kallio et al.,
1998). We exposed pregnant mice to 9% oxygen for 3 or 8 h at E9.5
(whilst control mice remained at normoxia), then harvested the
embryos and performed immunoﬂuorescence in wholemount.
Nuclear HIF1α was not detected in any region of control embryos
(Fig. 5D–F) or those exposed for 3 h (not shown), whereas
embryos exposed for 8 h had readily detectable levels of nuclear
HIF1α speciﬁcally localized in the myocardium (Fig. 5G–I). To
determine if this result reﬂected an intrinsic susceptibility of
myocardium to hypoxia, we next examined the localization of
HIF1α under increased hypoxic stress. We exposed wild type
embryos to the lowest possible oxygen level (5.5% oxygen for
8 h, Sparrow et al., 2012), and used immunoﬂuorescence to detect
HIF1α protein (Fig. S6). In these embryos, nuclear HIF1α was once
again detected in the myocardium (Fig. S6F) and also in gut
epithelium (data not shown). Low level nuclear accumulation
was also detectable in forebrain epithelium (Fig. S6H). Taken
together, these data demonstrate that short-term maternal expo-
sure to mildly lowered oxygen levels (9%) at E9.5 is sufﬁcient to
cause cellular hypoxia in the embryos by 3 h, and localization of
HIF1α protein to the nucleus of embryonic myocardial cells by 8 h.
Furthermore, the vast majority of HIF1α protein accumulation was
in myocardial cells, suggesting that this tissue is likely to be much
more susceptible to non-physiological hypoxia than the other
tissues of the developing embryo.
Myocardial proliferation is reduced in hearts lacking Hif1α
Short-term exposure of embryos in utero to reduced oxygen
levels caused accumulation of HIF1α protein in the nucleus of the
myocardium. Additionally, it caused rapid demise of embryos that
were unable to respond to this hypoxic insult due to the lack of
Hif1α in the heart. As embryo death did not appear to be due to a
disruption of gross heart morphology, we next examined the
cellular response of myocardium lacking Hif1α to cellular hypoxia.
In particular, we investigated cell proliferation and cell death. We
exposed pregnant mice to 9% oxygen for 8 h at E9.5 (whilst control
mice remained at normoxia), and then harvested the embryos
immediately after maternal exposure. To examine proliferation,
these embryos were co-stained with an antibody for phosphory-
lated Histone H3 and the nuclear marker DAPI, and the myocardial
mitotic index calculated (Fig. 6). Embryos lacking Hif1α in the
heart showed a signiﬁcant drop in the myocardial mitotic index
compared with control genotypes. This drop occurred regardless
of whether or not their mothers had been exposed to reduced
oxygen levels. By contrast, for both wild type embryos and
embryos lacking Hif1α in the heart, maternal exposure to 9%
oxygen did not cause signiﬁcantly reduced myocardial prolifera-
tion compared with unexposed embryos (Fig. 6F). To examine cell
death, embryos generated as described above were stained with
LysoTracker Red (Life Technologies). Surprisingly, staining was
completely absent from the heart, despite being present elsewhere
in the embryo, regardless of genotype or oxygen concentration
(data not shown). These data demonstrate that myocardial pro-
liferation is signiﬁcantly reduced in hearts lacking Hif1α compared
with controls, but that maternal exposure to reduced oxygen
levels does not alter embryonic myocardial cell proliferation or
cell death. Therefore the hypoxia-induced death of embryos
lacking cardiac Hif1α is not due to a lack of cellular proliferation
in the heart, or to an increase in cell death.
Discussion
Hif1α deletion from the mouse conceptus leads to completely
penetrant embryonic lethality by E10 due to a collapse in the
development of the cardiovascular system of the embryo, yolksac
and placenta (Compernolle et al., 2003; Cowden Dahl et al., 2005;
Iyer et al., 1998; Kotch et al., 1999; Ryan et al., 1998). These studies
have shown that Hif1α is required for normal development, but
they do not speciﬁcally identify the tissues in which Hif1α
functions, or if Hif1α is actually required in the embryo when
the placenta is functioning (which is not the case in the complete
Hif1α null). We have addressed these issues by conditionally
deleting Hif1α from speciﬁc cell types and tissues, resulting in a
number of key ﬁndings. Most signiﬁcantly, we demonstrate that
Hif1α is not required for development of the cardiovascular system
when the embryo develops in the context of a functioning
placenta. Additionally, we ﬁnd that Hif1α is primarily required in
the heart when the embryo is exposed to lowered oxygen
conditions.
Firstly, we showed that Hif1α is not required in VECs of the
embryo, yolksac or placenta for either normal morphological
development or for embryo survival, using conditional deletion
with Tek-Cre. However there was an impact on embryo and
placental growth, and a slight but non-signiﬁcant increase in the
prevalence of heart defects. This lack of lethality might have been
predicted as progeny of a Hif1αﬂox/ﬂox Tek-Cre intercross survive
to adulthood (Tang et al., 2004). However in that study, an
embryonic phenotype may have been averted due to incomplete
conditional deletion of Hif1α throughout the conceptus during
development. Others have reported incomplete Hif1α deletion
when using homozygous Hif1αﬂox alleles (Krishnan et al., 2008;
Mason et al., 2004). By contrast, our study design maximized Hif1α
deletion in VECs by using Hif1αΔ/ﬂox embryos that only require
Tek-Cre to act on a single Hif1αﬂox allele. Our ﬁnding that Hif1α is
not overtly required in VECs during development is intriguing, as
Hif1α is required for angiogenesis during wound healing and
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Fig. 5. Maternal exposure to lowered oxygen levels causes embryonic hypoxia and stabilization of HIF1α. Quantiﬁcation of hypoxyprobe™ adducts from E9.5 hearts of
embryos exposed in utero to 8% oxygen for 3 h. (A) Representative western blot, and (B) summary of quantiﬁcation of adducts. β-Tubulin was used as the loading control.
Error bars indicate standard deviations. Statistical signiﬁcance was tested using Student's t-test on data transformed using natural logarithms to correct for zero-bounded
bounded data. nnnpo0.001. (C–I) Comparison of HIF1α protein levels in E9.5 wild type mouse embryos from unexposed (21% oxygen) litters (D–F) and litters exposed to 9%
oxygen for 8 h immediately prior to harvest (G–I) using wholemount immunoﬂuorescence. (D, E) Saggital optical sections of whole embryos stained for HIF1α protein; (G, H)
nuclei stained with TO-PRO-3; (F, I) merged images with magniﬁed views of the myocardium in inset panels. The schematic in (C) indicates the approximate orientation of
the sections within the embryo. The scale bar represents 100 μm (D–I) and 40 μm (inset panels F, I). ac¼Atrial chamber, ba¼branchial arch, ne¼neurectoderm, oft¼outﬂow
tract, rv¼right ventricle.
V.C. O'Reilly et al. / Developmental Biology 391 (2014) 99–110 107
tumorigenesis in adult mice (Tang et al., 2004). Our results suggest
that embryonic and adult angiogenesis is different; this may
reﬂect differences in the ability of tissues surrounding the VECs
to respond to VEC-mediated HIF1α-induced signals. In support of
our ﬁndings, Imanirad et al. (2013) have very recently reported
that deletion of Hif1α from VECs using another Cre-expressing
transgene, also does not affect embryo development or survival.
In contrast to deletion of Hif1α from trophoblasts or VECs,
deletion of Hif1α from a broad range of mesoderm using the
MesP1Cre allele caused signiﬁcant embryo death and signiﬁcantly
increased the prevalence of heart defects. To more speciﬁcally
deﬁne in which mesodermal tissues Hif1α functions, we used the
Nkx2-5IRESCre allele to delete Hif1α within a more restricted
embryonic domain, the heart. We found that Hif1α is not
Fig. 6. Myocardial proliferation is reduced in hearts lacking Hif1α. (A–D) Representative saggital optical sections of E9.5 mouse embryos stained using wholemount
immunoﬂuorescence for phosphorylated Histone H3 (red), with nuclei stained using DAPI (blue). (A, C) control genotypes and (B, D) conditionally-deleted embryos lacking
Hif1α in the heart, from unexposed (21% oxygen) litters (A, B) or litters exposed to 9% oxygen for 8 h immediately prior to harvest (C, D). The scale bar represents 100 μm.
(E) A schematic indicating the approximate orientation of the sections in the embryo. (F) Summary of the quantitation of myocardial mitotic index. Error bars indicate
standard deviations. Statistical signiﬁcance was tested using Student's t-test. nnpo0.01, nnnpo0.001. ac¼Atrial chamber, ba¼branchial arch, ne¼neurectoderm,
oft¼outﬂow tract, rv¼right ventricle. C represents pooled embryos from all three control genotypes, and Hf/HΔ Creþ represents conditionally deleted embryos.
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speciﬁcally required in the heart for normal morphological devel-
opment or embryo survival. As with deletion of Hif1α in VECs,
there was an impact on embryo and placenta growth and an
increased, but non-signiﬁcant, prevalence of heart defects. These
ﬁndings are in contrast with previous work where Hif1α was
deleted using MLC2v-Cre (Krishnan et al., 2008). In that study,
heart development arrested with myocardial hyperplasia at E10,
and lethality occurred by E11-12. It is difﬁcult to reconcile this
severe phenotype with the mild one we observe since MLC2v-Cre
is expressed later in development and is also expressed in a much
more restricted pattern (ﬁrst heart ﬁeld and derivatives) than
Nkx2-5IRESCre (ﬁrst and second heart ﬁelds and derivatives, Chen et
al., 1998; Li et al., 2011; Stanley et al., 2002). In addition, our study
had a more complete deletion of Hif1α: Krishnan et al. (2008)
show that Hif1α mRNA levels in their system are reduced by only
35–80% in Hif1αΔ/ﬂox; MLC2v-Cre hearts at E8.75-9.25, while we
showed complete absence of Hif1α genomic DNA and mRNA in
Hif1αΔ/ﬂox; Nkx2-5IRESCreþ / hearts at E9.5. One explanation for the
different phenotypes observed in these two studies is that each
used a different Hif1α null allele (Dunwoodie, 2009). Krishnan
et al. (2008) used a Hif1α null allele that causes myocardial
hyperplasia in homozygous Hif1α null embryos (Iyer et al., 1998).
This null allele contains an active PGK promoter driving expression
of the neo gene. The Hif1α null allele used in our study does not
contain PGK-neo, and does not cause myocardial hyperplasia (Ryan
et al., 1998). A third Hif1α allele exists that also lacks myocardial
hyperplasia (Compernolle et al., 2003). It is therefore possible that
the myocardial hyperplasia and embryonic lethality reported by
Krishnan et al. (2008) stems from the particular Hif1α null allele
used, rather than the loss of Hif1α in the myocardium per se
(Dunwoodie, 2009). It is also possible that the genetic background
of the mice used in the different studies has bearing on the
phenotype. Our study used C57BL/6J mice (410 backcrosses)
whilst Krishnan et al. (2008) used mice of mixed background
(C57BL/6; 129SvJ; 129S1).
Our ﬁnal ﬁnding may have clinical relevance. It concerns the
hitherto unappreciated vulnerability of the developing heart to
hypoxia. In order to recapitulate the gestational environment of
the Hif1α homozygous null conceptus (Compernolle et al., 2003;
Cowden Dahl et al., 2005; Iyer et al., 1998; Kotch et al., 1999; Ryan
et al., 1998), we exposed pregnant female mice carrying embryos
lacking Hif1α in the heart to short-term lowered oxygen levels so
as to mimic the embryonic hypoxia experienced by these complete
Hif1α nulls due to lack of placental function. We showed that the
majority of embryos lacking Hif1α in the heart died following such
exposure. Embryo death did not appear to result from a disruption
of heart morphology, nor from an increase in cell death or
decrease in cellular proliferation. These data provide compelling
evidence that the lethality seen in complete Hif1α null embryos
occurs because the heart fails if it does not have Hif1α to respond
to the non-physiological hypoxia caused by placental insufﬁciency.
Our study demonstrates the vulnerability of the heart to lowered
levels of oxygen, as under such hypoxic conditions the embryo
absolutely requires Hif1α in the heart to survive. We discovered
that this is a heart-speciﬁc phenomenon, at least at E9.5-10.5, as
we showed that HIF1α accumulated predominantly in the myo-
cardium of embryos exposed to either a mild or severe reduction
in oxygen. Consideration of the physiology of the developing heart,
a uniquely active tissue in the embryo, suggests a possible
mechanism for the embryonic lethality in the absence of structural
heart defects. The energetic needs of the post implantation mouse
embryo (E5.6-E6.5) are almost entirely met in this low oxygen
environment by glycolysis (Wales et al., 1995). As development
proceeds, the proportion of energy derived from glucose oxidation
increases with the increasing vascularization of the embryo.
However at E9.5 oxidative phosphorylation is still a minor
contributor (Folmes et al., 2012a, 2012b; Wales et al., 1995). At
this stage cardiomyocytes have only a few fragmented mitochon-
dria with poorly deﬁned and organized cristae, and so are
primarily dependent on anaerobic glycolysis for ATP generation,
as is the rest of the embryo (Hom et al., 2011; Wales et al., 1995).
Extensive growth is a feature of subsequent embryonic develop-
ment (E9.5-13.5). Such growth can only be sustained with elevated
cardiac output, and the increasing bioenergetic demands of the
cardiomyocytes require efﬁcient oxidative ATP generation. Net-
works of elongated and branched mitochondria with abundant
organized cristae are a feature of cardiomyocytes at E13.5 (Hom et
al., 2011). Thus between E9.5 and E13.5 is a critical time for the
embryo as cardiomyocytes transition between anaerobic and
aerobic glycolysis. This transition needs to be balanced against
the increasing cardiovascular requirements of the rapidly growing
embryo. Clearly an adequate oxygen supply is crucial for this
transition and for sustaining embryonic growth and viability. Thus
it might be predicted that when we expose embryos to lowered
oxygen levels at E9.5 for 8 h, we disrupt this critical balance
between embryonic growth demands, contractility of the myocar-
dium, ATP requirement and oxygen. Such a disruption is clearly
seen in the accumulation of nuclear HIF1α in the myocardium,
indicating that there is insufﬁcient oxygen to sustain the metabolic
activity of the cardiomyocytes. However in the absence of Hif1α,
the effects of hypoxia cannot be redressed by the normal com-
pensatory mechanisms co-ordinated by HIF1α. Failure of these
compensatory mechanisms then rapidly results in signiﬁcant
embryonic lethality.
Our discovery that the heart is extremely vulnerable to reduced
levels of oxygen is potentially clinically relevant for two reasons.
Firstly, during embryonic development, short-term exposure to
low oxygen causes cellular hypoxia of the myocardium. This,
coupled with a genetic predisposition that impairs any of the
systems that deliver, monitor and/or respond to oxygen, or are
required for cardiomyocyte contractile function, or mitochondria
and energy metabolism, may lead to death in utero. Secondly, in
cases of congenital heart disease where chronic underperformance
of the cardiovascular system occurs even post-surgery, such as in
hyperplastic left heart syndrome, an impaired response to cardi-
omyocyte hypoxia (Gaber et al., 2013) may explain the variable
outcomes experienced by these patients. In conclusion, our Hif1α-
centered studies shed light on these clinical situations and may in
time lead to identiﬁcation of individuals at increased risk of death
in utero or after cardiac surgery, and to the development of
preventative therapies.
Sources of funding
The work was supported by the Australian National Health and
Medical Research Council: Project Grants 303705, 404805 and
1019776; and Senior Research Fellowships 514900 and 1042002.
Disclosures
None.
Acknowledgments
We thank Yumiko Saga for providing mouse lines; BioCORE
staff; and Herbert Smith for generously donating the confocal
microscope used in this study.
V.C. O'Reilly et al. / Developmental Biology 391 (2014) 99–110 109
Appendix A. Supporting information
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.ydbio.2014.03.005.
References
Amarilio, R., Viukov, S.V., Sharir, A., Eshkar-Oren, I., Johnson, R.S., Zelzer, E., 2007.
HIF1alpha regulation of Sox9 is necessary to maintain differentiation of hypoxic
prechondrogenic cells during early skeletogenesis. Development 134,
3917–3928.
Carreau, A., El Hafny-Rahbi, B., Matejuk, A., Grillon, C., Kieda, C., 2011. Why is the
partial oxygen pressure of human tissues a crucial parameter? Small molecules
and hypoxia. J. Cell Mol. Med. 15, 1239–1253.
Chen, J., Kubalak, S.W., Chien, K.R., 1998. Ventricular muscle-restricted targeting of
the RXRalpha gene reveals a non-cell-autonomous requirement in cardiac
chamber morphogenesis. Development 125, 1943–1949.
Compernolle, V., Brusselmans, K., Franco, D., Moorman, A., Dewerchin, M., Collen,
D., Carmeliet, P., 2003. Cardia biﬁda, defective heart development and abnormal
neural crest migration in embryos lacking hypoxia-inducible factor-1alpha.
Cardiovasc. Res. 60, 569–579.
Constien, R., Forde, A., Liliensiek, B., Grone, H.J., Nawroth, P., Hammerling, G.,
Arnold, B., 2001. Characterization of a novel EGFP reporter mouse to monitor
Cre recombination as demonstrated by a Tie2 Cre mouse line. Genesis 30,
36–44.
Cowden Dahl, K.D., Fryer, B.H., Mack, F.A., Compernolle, V., Maltepe, E., Adelman, D.
M., Carmeliet, P., Simon, M.C., 2005. Hypoxia-inducible factors 1alpha and
2alpha regulate trophoblast differentiation. Mol. Cell Biol. 25, 10479–10491.
Dunwoodie, S.L., 2009. The role of hypoxia in development of the Mammalian
embryo. Dev. Cell 17, 755–773.
Eisinger-Mathason, T.S., Zhang, M., Qiu, Q., Skuli, N., Nakazawa, M.S., Karakasheva,
T., Mucaj, V., Shay, J.E., Stangenberg, L., Sadri, N., Pure, E., Yoon, S.S., Kirsch, D.G.,
Simon, M.C., 2013. Hypoxia-dependent modiﬁcation of collagen networks
promotes sarcoma metastasis. Cancer Discov. 3, 1190–1205.
Eltzschig, H.K., Carmeliet, P., 2011. Hypoxia and inﬂammation. N. Engl. J. Med. 364,
656–665.
Folmes, C.D., Dzeja, P.P., Nelson, T.J., Terzic, A., 2012a. Metabolic plasticity in stem
cell homeostasis and differentiation. Cell Stem Cell 11, 596–606.
Folmes, C.D., Dzeja, P.P., Nelson, T.J., Terzic, A., 2012b. Mitochondria in control of cell
fate. Circ. Res. 110, 526–529.
Gaber, N., Gagliardi, M., Patel, P., Kinnear, C., Zhang, C., Chitayat, D., Shannon, P.,
Jaeggi, E., Tabori, U., Keller, G., Mital, S., 2013. Fetal reprogramming and
senescence in hypoplastic left heart syndrome and in human pluripotent stem
cells during cardiac differentiation. Am. J. Pathol. 183, 720–734.
Geffers, I., Serth, K., Chapman, G., Jaekel, R., Schuster-Gossler, K., Cordes, R.,
Sparrow, D.B., Kremmer, E., Dunwoodie, S.L., Klein, T., Gossler, A., 2007.
Divergent functions and distinct localization of the Notch ligands DLL1 and
DLL3 in vivo. J. Cell Biol. 178, 465–476.
Hom, J.R., Quintanilla, R.A., Hoffman, D.L., de Mesy Bentley, K.L., Molkentin, J.D.,
Sheu, S.S., Porter Jr, G.A., 2011. The permeability transition pore controls cardiac
mitochondrial maturation and myocyte differentiation. Dev. Cell 21, 469–478.
Huang, L.E., Arany, Z., Livingston, D.M., Bunn, H.F., 1996. Activation of hypoxia-
inducible transcription factor depends primarily upon redox-sensitive stabili-
zation of its alpha subunit. J. Biol. Chem. 271, 32253–32259.
Huang, Y., Hickey, R.P., Yeh, J.L., Liu, D., Dadak, A., Young, L.H., Johnson, R.S.,
Giordano, F.J., 2004. Cardiac myocyte-speciﬁc HIF-1alpha deletion alters vascu-
larization, energy availability, calcium ﬂux, and contractility in the normoxic
heart. FASEB J. 18, 1138–1140.
Imanirad, P., Solaimani Kartalaei, P., Crisan, M., Vink, C., Yamada-Inagawa, T., de
Pater, E., Kurek, D., Kaimakis, P., van der Linden, R., Speck, N., Dzierzak, E., 2013.
HIF1alpha is a regulator of hematopoietic progenitor and stem cell develop-
ment in hypoxic sites of the mouse embryo. Stem Cell Res. 12, 24–35.
Iyer, N.V., Kotch, L.E., Agani, F., Leung, S.W., Laughner, E., Wenger, R.H., Gassmann,
M., Gearhart, J.D., Lawler, A.M., Yu, A.Y., Semenza, G.L., 1998. Cellular and
developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha.
Genes Dev. 12, 149–162.
Jiang, B.H., Semenza, G.L., Bauer, C., Marti, H.H., 1996. Hypoxia-inducible factor
1 levels vary exponentially over a physiologically relevant range of O2 tension.
Am. J. Physiol. 271, C1172–C1180.
Kallio, P.J., Okamoto, K., O’Brien, S., Carrero, P., Makino, Y., Tanaka, H., Poellinger, L.,
1998. Signal transduction in hypoxic cells: inducible nuclear translocation and
recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-
1alpha. EMBO J. 17, 6573–6586.
Kennedy, A.S., Raleigh, J.A., Perez, G.M., Calkins, D.P., Thrall, D.E., Novotny, D.B.,
Varia, M.A., 1997. Proliferation and hypoxia in human squamous cell carcinoma
of the cervix: ﬁrst report of combined immunohistochemical assays. Int. J.
Radiat. Oncol. Biol. Phys. 37, 897–905.
Kisanuki, Y.Y., Hammer, R.E., Miyazaki, J., Williams, S.C., Richardson, J.A., Yanagi-
sawa, M., 2001. Tie2-Cre transgenic mice: a new model for endothelial cell-
lineage analysis in vivo. Dev. Biol. 230, 230–242.
Koni, P.A., Joshi, S.K., Temann, U.A., Olson, D., Burkly, L., Flavell, R.A., 2001.
Conditional vascular cell adhesion molecule 1 deletion in mice: impaired
lymphocyte migration to bone marrow. J. Exp. Med. 193, 741–754.
Kotch, L.E., Iyer, N.V., Laughner, E., Semenza, G.L., 1999. Defective vascularization of
HIF-1alpha-null embryos is not associated with VEGF deﬁciency but with
mesenchymal cell death. Dev. Biol. 209, 254–267.
Krishnan, J., Ahuja, P., Bodenmann, S., Knapik, D., Perriard, E., Krek, W., Perriard, J.C.,
2008. Essential role of developmentally activated hypoxia-inducible factor
1alpha for cardiac morphogenesis and function. Circ. Res. 103, 1139–1146.
Land, S.C., 2004. Hochachka’s “Hypoxia Defense Strategies” and the development of
the pathway for oxygen. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 139,
415–433.
Lando, D., Peet, D.J., Gorman, J.J., Whelan, D.A., Whitelaw, M.L., Bruick, R.K., 2002a.
FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional
activity of hypoxia-inducible factor. Genes Dev. 16, 1466–1471.
Lando, D., Peet, D.J., Whelan, D.A., Gorman, J.J., Whitelaw, M.L., 2002b. Asparagine
hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295,
858–861.
Lee, Y.M., Jeong, C.H., Koo, S.Y., Son, M.J., Song, H.S., Bae, S.K., Raleigh, J.A., Chung, H.
Y., Yoo, M.A., Kim, K.W., 2001. Determination of hypoxic region by hypoxia
marker in developing mouse embryos in vivo: a possible signal for vessel
development. Dev. Dyn. 220, 175–186.
Lendahl, U., Lee, K.L., Yang, H., Poellinger, L., 2009. Generating speciﬁcity and
diversity in the transcriptional response to hypoxia. Nat. Rev. Genet. 10,
821–832.
Li, P., Cavallero, S., Gu, Y., Chen, T.H., Hughes, J., Hassan, A.B., Bruning, J.C.,
Pashmforoush, M., Sucov, H.M., 2011. IGF signaling directs ventricular cardio-
myocyte proliferation during embryonic heart development. Development 138,
1795–1805.
Mahy, P., De Bast, M., Gallez, B., Gueulette, J., Koch, C.J., Scalliet, P., Gregoire, V.,
2003. in vivo colocalization of 2-nitroimidazole EF5 ﬂuorescence intensity and
electron paramagnetic resonance oximetry in mouse tumors. Radiother. Oncol.
67, 53–61.
Mason, S.D., Howlett, R.A., Kim, M.J., Olfert, I.M., Hogan, M.C., McNulty, W., Hickey,
R.P., Wagner, P.D., Kahn, C.R., Giordano, F.J., Johnson, R.S., 2004. Loss of skeletal
muscle HIF-1alpha results in altered exercise endurance. PLoS Biol. 2, e288.
Prabhakar, N.R., Semenza, G.L., 2012. Adaptive and maladaptive cardiorespiratory
responses to continuous and intermittent hypoxia mediated by hypoxia-
inducible factors 1 and 2. Physiol. Rev. 92, 967–1003.
Provot, S., Zinyk, D., Gunes, Y., Kathri, R., Le, Q., Kronenberg, H.M., Johnson, R.S.,
Longaker, M.T., Giaccia, A.J., Schipani, E., 2007. Hif-1alpha regulates differentia-
tion of limb bud mesenchyme and joint development. J. Cell Biol. 177, 451–464.
Raleigh, J.A., Chou, S.C., Arteel, G.E., Horsman, M.R., 1999. Comparisons among
pimonidazole binding, oxygen electrode measurements, and radiation response
in C3H mouse tumors. Radiat. Res. 151, 580–589.
Ream, M., Ray, A.M., Chandra, R., Chikaraishi, D.M., 2008. Early fetal hypoxia leads
to growth restriction and myocardial thinning. Am. J. Physiol. Regul. Integr.
Comp. Physiol. 295, R583–R595.
Rosset, A., Spadola, L., Ratib, O., 2004. OsiriX: an open-source software for
navigating in multidimensional DICOM images. J. Digit Imaging 17, 205–216.
Ryan, H.E., Lo, J., Johnson, R.S., 1998. HIF-1 alpha is required for solid tumor
formation and embryonic vascularization. EMBO J. 17, 3005–3015.
Ryan, H.E., Poloni, M., McNulty, W., Elson, D., Gassmann, M., Arbeit, J.M., Johnson, R.
S., 2000. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor
growth. Cancer Res. 60, 4010–4015.
Saga, Y., Miyagawa-Tomita, S., Takagi, A., Kitajima, S., Miyazaki, J., Inoue, T., 1999.
MesP1 is expressed in the heart precursor cells and required for the formation
of a single heart tube. Development 126, 3437–3447.
Schlaeger, T.M., Bartunkova, S., Lawitts, J.A., Teichmann, G., Risau, W., Deutsch, U.,
Sato, T.N., 1997. Uniform vascular-endothelial-cell-speciﬁc gene expression in
both embryonic and adult transgenic mice. Proc. Natl. Acad. Sci. USA 94,
3058–3063.
Schneider, J.E., Cassidy, P.J., Lygate, C., Tyler, D.J., Wiesmann, F., Grieve, S.M., Hulbert,
K., Clarke, K., Neubauer, S., 2003. Fast, high-resolution in vivo cine magnetic
resonance imaging in normal and failing mouse hearts on a vertical 11.7T
system. J. Magn. Reson. Imaging 18, 691–701.
Sparrow, D.B., Boyle, S.C., Sams, R.S., Mazuruk, B., Zhang, L., Moeckel, G.W.,
Dunwoodie, S.L., de Caestecker, M.P., 2009. Placental insufﬁciency associated
with loss of Cited1 causes renal medullary dysplasia. J. Am. Soc. Nephrol. 20,
777–786.
Sparrow, D.B., Chapman, G., Smith, A.J., Mattar, M.Z., Major, J.A., O’Reilly, V.C., Saga,
Y., Zackai, E.H., Dormans, J.P., Alman, B.A., McGregor, L., Kageyama, R., Kusumi,
K., Dunwoodie, S.L., 2012. A mechanism for gene–environment interaction in
the etiology of congenital scoliosis. Cell 149, 295–306.
Stanley, E.G., Biben, C., Elefanty, A., Barnett, L., Koentgen, F., Robb, L., Harvey, R.P.,
2002. Efﬁcient Cre-mediated deletion in cardiac progenitor cells conferred by a
30UTR-ires-Cre allele of the homeobox gene Nkx2-5. Int. J. Dev. Biol. 46,
431–439.
Tang, N., Wang, L., Esko, J., Giordano, F.J., Huang, Y., Gerber, H.P., Ferrara, N., Johnson,
R.S., 2004. Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven
VEGF autocrine loop necessary for tumorigenesis. Cancer Cell 6, 485–495.
Wales, R.G., Martin, K.L., Leese, H.J., 1995. Glucose utilization by components of the
mouse conceptus during early embryogenesis. J. Reprod. Fertil. 104, 125–132.
Wang, G.L., Jiang, B.H., Rue, E.A., Semenza, G.L., 1995. Hypoxia-inducible factor 1 is a
basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc.
Natl. Acad. Sci. USA 92, 5510–5514.
Yu, A.Y., Frid, M.G., Shimoda, L.A., Wiener, C.M., Stenmark, K., Semenza, G.L., 1998.
Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible fac-
tor-1 in the lung. Am. J. Physiol. 275, L818–L826.
V.C. O'Reilly et al. / Developmental Biology 391 (2014) 99–110110
